140 related articles for article (PubMed ID: 2992530)
1. Suloctidil: long-term trial in the aged. Study of microcirculation, viscosity, red cell deformability, fibrinolysis and lipid fractions.
Merchan R; Zurita IE; Martinez JF
Arzneimittelforschung; 1985; 35(5):855-7. PubMed ID: 2992530
[TBL] [Abstract][Full Text] [Related]
2. Effects of long-term treatment with suloctidil on blood viscosity, erythrocyte deformability and total fibrinogen plasma levels in diabetic patients.
Roncucci R; De Hertogh R; Dormandy JA; Doumont J; Gurewich V; Lambelin G; Lansen J; Rottiers R; Souridis E; Van Stalle F; Versee L
Arzneimittelforschung; 1979; 29(4):682-4. PubMed ID: 582768
[TBL] [Abstract][Full Text] [Related]
3. [Chronic senile cerebrovascular insufficiency. Effects of suloctidil and pentoxifylline on erythrocyte deformability].
Pilla G; Ciaponi A; Migliavacca A; Bonora C
Ric Clin Lab; 1983; 13 Suppl 3():459-64. PubMed ID: 6324325
[TBL] [Abstract][Full Text] [Related]
4. [Hemorrheological survey in a group with arteriosclerotic vascular disease treated with suloctidil].
Caimi G; Catania A; Frazzetta F; Capobianco D; Francavilla G; Romano A; Sarno A
Ric Clin Lab; 1983; 13 Suppl 3():465-8. PubMed ID: 6324326
[TBL] [Abstract][Full Text] [Related]
5. Effect of parenteral or oral vinpocetine on the hemorheological parameters of patients with chronic cerebrovascular diseases.
Feher G; Koltai K; Kesmarky G; Horvath B; Toth K; Komoly S; Szapary L
Phytomedicine; 2009 Mar; 16(2-3):111-7. PubMed ID: 19135345
[TBL] [Abstract][Full Text] [Related]
6. Double-blind trial of suloctidil versus placebo in moderate to severe mental deterioration.
Baro F; Malfroid M; Waegemans T; Cox JP
Pharmatherapeutica; 1985; 4(6):399-404. PubMed ID: 3001778
[TBL] [Abstract][Full Text] [Related]
7. The effect of recombinant human erythropoietin on hemostasis, fibrinolysis, and blood rheology in autologous blood donors.
Biesma DH; Bronkhorst PJ; de Groot PG; van de Wiel A; Kraaijenhagen RJ; Marx JJ
J Lab Clin Med; 1994 Jul; 124(1):42-7. PubMed ID: 8035101
[TBL] [Abstract][Full Text] [Related]
8. Clinical and biological activity of the antiplatelet agent suloctidil in treatment of idiopathic recurrent vein thrombosis (I.R.V.T.).
Moriau M; Col-De Beys C; Pardonge E; Ferrant A
Thromb Haemost; 1982 Feb; 47(1):27-31. PubMed ID: 6280332
[TBL] [Abstract][Full Text] [Related]
9. Activation of platelets and of fibrinolysis by venous occlusion in healthy volunteers and influence of suloctidil in comparison with placebo.
Baele G; Bary JL; van Stalle F
Arzneimittelforschung; 1983; 33(8):1203-5. PubMed ID: 6315025
[TBL] [Abstract][Full Text] [Related]
10. Hemorheological changes after intravenous gammaglobulin administration in patients with neurological disorders.
Kowal P; Zmyślony A
Clin Hemorheol Microcirc; 2008; 40(3):229-34. PubMed ID: 19029646
[TBL] [Abstract][Full Text] [Related]
11. [Changes in blood viscosity and erythrocyte deformability in patients with dyslipidemia treated with binifibrate].
Labiós Gómez M; Romero Simo M; Gabriel Botella F; Martín Valles H; Morera Llorca M; Freixas Ventura J
An Med Interna; 1990 Oct; 7(10):517-21. PubMed ID: 2104097
[TBL] [Abstract][Full Text] [Related]
12. [Role of the blood platelets in the atherosclerotic process and clinical use of a new drug, Suloctidil, with anti-aggregating activity].
Armani U; Piana A
Arch Maragliano Patol Clin; 1979; 35(2):57-62. PubMed ID: 233645
[No Abstract] [Full Text] [Related]
13. [Hemorheologic therapy applications in coronary heart disease].
Leschke M; Motz W; Strauer BE
Wien Med Wochenschr; 1986; 136 Spec No():17-24. PubMed ID: 3825169
[TBL] [Abstract][Full Text] [Related]
14. [Suloctidil (sulocton) in the treatment of atherosclerotic neurasthenic syndromes].
Prusiński A; Kotwica S; Niewodniczy A; Split W
Wiad Lek; 1982 May; 35(3-4):201-5. PubMed ID: 6287740
[No Abstract] [Full Text] [Related]
15. The effect of pentaerithrityl-tetranitrate on parameters of the microcirculation.
Böhm C; Haustein KO
Int J Clin Pharmacol Ther; 1998 Jul; 36(7):398-402. PubMed ID: 9707356
[TBL] [Abstract][Full Text] [Related]
16. The effect of simvastatin therapy on hemorheological profile in coronary heart desease (CHD) patients.
Muravyov AV; Yakusevich VV; Surovaya L; Petrochenko A
Clin Hemorheol Microcirc; 2004; 31(4):251-6. PubMed ID: 15567894
[TBL] [Abstract][Full Text] [Related]
17. [Further observations on the use of Suloctidil (Sulocton) in the treatment of migraine].
Prusiński A; Durko A; Głuszcz-Zielińska A; Szymańska R
Wiad Lek; 1984 Dec; 37(23):1857-9. PubMed ID: 6099634
[No Abstract] [Full Text] [Related]
18. [Clinical trial of suloctidil (sulocton) for the treatment of migraine (preliminary report)].
Prusiński A
Neurol Neurochir Pol; 1981; 15(3):309-11. PubMed ID: 6273762
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy of troxerutin on the flow properties of blood under defined conditions of circulation. A double-blind study of patients with diabetic retinopathy and arteriosclerotic retinopathy].
Gallasch G; Dörfer C; Schmitt T; Stage A
Klin Monbl Augenheilkd; 1985 Jul; 187(1):30-5. PubMed ID: 3906246
[TBL] [Abstract][Full Text] [Related]
20. [Medium term treatment with suloctidil in obliterating arteriopathies of the lower limbs. Personal experience].
Marongiu G; Dettori G; Gadeddu A; Noya G; Angius P; Biglioli P
Minerva Cardioangiol; 1983; 31(7-8):407-10. PubMed ID: 6316206
[No Abstract] [Full Text] [Related]
[Next] [New Search]
